AB0311 Results of Screening for Tuberculosis Infection in Patients With Rheumatoid Arthritis Before and on Treatment With Biological Dmards

doi 10.1136/annrheumdis-2017-eular.6988
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

AB0432 Biologic Dmards Treatment Retention in Patients With Rheumatoid Arthritis According to the Moscow Arthritis Registry (MERA)

2018English

Treatment of Rheumatoid Arthritis in Patients With Concomitant Chronic Hepatitis C Infection

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2011English

Biological Therapy and Infection in Rheumatoid Arthritis Patients: Modern Aspects

Medical Council
2016English

Quality of Life in Rheumatoid Arthritis Patients Taking Combination DMARDs

Journal of Medical Science And clinical Research
2017English

Risk of Serious Infection in Patients With Rheumatoid Arthritis

Japanese Journal of Clinical Immunology
2015English

Regulatory T Cell Frequencies in Patients With Rheumatoid Arthritis Are Increased by Conventional and Biological DMARDs but Not by JAK Inhibitors

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

SAT0193 Early Discontinuation of First Line Biological Treatment With Etanercept in Patients With Rheumatoid Arthritis: Results From the Italian Gisea Registry

2018English

Histoplasmosis Infection in Patients With Rheumatoid Arthritis, 1998-2009

BMC Infectious Diseases
Infectious Diseases
2011English

Pms30 - Cost Analysis for Different Anti-Rheumatoid Biological Treatments After Failure of Conventional Dmards in Patients With Moderate to Severe Rheumatoid Arthritis in the Kingdom of Saudi Arabia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy